110 related articles for article (PubMed ID: 321912)
1. [7-year therapy of chronic obliterating vascular diseases].
König FK
Med Welt; 1977 Feb; 28(7):350-3. PubMed ID: 321912
[No Abstract] [Full Text] [Related]
2. [A new drug in the treatment of chronic arterial diseases of the limbs].
Schmidt C; Royer RJ; Schmitt J
Sem Hop; 1978 Feb; 54(4):210-3. PubMed ID: 208169
[No Abstract] [Full Text] [Related]
3. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
[No Abstract] [Full Text] [Related]
4. [Effect of bencyclane on the visual field in glaucoma].
Szymaniak R; Szczypiński J; Sek B
Klin Oczna; 1987 Mar; 89(3):100-1. PubMed ID: 3309448
[No Abstract] [Full Text] [Related]
5. [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].
Krähenbühl B
Schweiz Rundsch Med Prax; 1975 May; 64(20):632-4. PubMed ID: 1099573
[No Abstract] [Full Text] [Related]
6. [Prolonged bencyclane (Halidor) therapy of symptomatic sinus bradycardia, sick sinus syndrome and atrioventricular block].
Széplaki S
Orv Hetil; 1979 Sep; 120(35):2113-6. PubMed ID: 390468
[No Abstract] [Full Text] [Related]
7. [Bencyclane (Fludilat) in the therapy of local cerebrovascular disorders].
Kohlmeyer K; Schneider E; Fischer PA; Jacobi P
Med Klin; 1977 Aug; 72(32-33):1311-2. PubMed ID: 331059
[No Abstract] [Full Text] [Related]
8. [Controlled study on the effect of a new substance in peripheral arterial diseases].
Poti R; Megha A; Pini M; Bulletti G
Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
[No Abstract] [Full Text] [Related]
9. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
Trübestein G; Trübestein R; Ludwig M
Fortschr Med; 1989 Dec; 107(36):781-4. PubMed ID: 2695437
[TBL] [Abstract][Full Text] [Related]
10. [Bencyclane (Halidor) in the treatment of migraine and similar headaches].
Klimek A
Wiad Lek; 1978 Sep; 31(17):1189-92. PubMed ID: 706375
[No Abstract] [Full Text] [Related]
11. [Combination of physiotherapeutic exercise therapy with bencyclane in intermittent claudication (author's transl)].
Krause D; Dittmar K
MMW Munch Med Wochenschr; 1976 Oct; 118(40):1281-4. PubMed ID: 824553
[TBL] [Abstract][Full Text] [Related]
12. [Effect of bencyclane on bronchodilation in bronchial asthma].
Marcisz C; Jonderko G; Kwiatek R; Polko M
Pol Tyg Lek; 1984 Oct; 39(43):1419-21. PubMed ID: 6514616
[No Abstract] [Full Text] [Related]
13. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
König FK
Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of fludilat in cerebrovascular insufficiency].
García Guerra CM
Prensa Med Mex; 1977; 42(11-12):504-8. PubMed ID: 351600
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
Garweg G; Herrmann WM; Kern U
Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of blood circulation disorders with a hemoactive-vasoactive drug].
Aguirre-Contreras JA; Meza y Gutiérrez E
Prensa Med Mex; 1977; 42(11-12):509-15. PubMed ID: 351601
[TBL] [Abstract][Full Text] [Related]
17. [Oral therapy with bencyclane. Changes in blood-flow characteristics and spontaneous thrombocyte aggregation during oral therapy with bencyclane].
Völker D
ZFA (Stuttgart); 1979 Jan; 55(3):182-7. PubMed ID: 419814
[No Abstract] [Full Text] [Related]
18. [A new way in the treatment of migraine. Evaluation of a field study].
Abel M; Schneider B
Med Welt; 1976 Aug; 27(32):1509-12. PubMed ID: 957978
[No Abstract] [Full Text] [Related]
19. [Control of the pharmacodynamic effect of fludilate in the management of cerebrovascular insufficiency].
Bartels H; Schneider B
Med Welt; 1978 Jun; 29(25):1056-60. PubMed ID: 661555
[No Abstract] [Full Text] [Related]
20. [Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
Széplaki S; Széplaki Z
MMW Munch Med Wochenschr; 1976 Mar; 118(10):309-12. PubMed ID: 817154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
